Patents by Inventor Charles J. Lowenstein

Charles J. Lowenstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • P-SELECTIN INHIBITOR, COMPOSITIONS THEREOF AND METHODS OF USE THEREOF
    Publication number: 20220403036
    Abstract: Provided herein are methods of uses of a P-selectin inhibitor alone or in combination with a Von Willebrand factor (VWF) inhibitor. The methods include the administration of a P-selectin inhibitor alone or in combination with a Von Willebrand factor (VWF) inhibitor for the treatment of COVID-19 associated endothelial injury and/or reducing the risk of thrombosis in a subject of need thereof.
    Type: Application
    Filed: June 16, 2022
    Publication date: December 22, 2022
    Inventor: Charles J. Lowenstein
  • Glutamate receptor antagonists and methods of use
    Patent number: 8603980
    Abstract: The present invention relates to methods and compositions for modulating platelet activity by inhibiting or activating glutamate receptors. The invention further relates to preventing or treating thrombotic diseases.
    Type: Grant
    Filed: January 16, 2008
    Date of Patent: December 10, 2013
    Assignee: The Johns Hopkins University
    Inventors: Craig N. Morrell, Charles J. Lowenstein
  • GLUTAMATE RECEPTOR ANTAGONISTS AND METHODS OF USE
    Publication number: 20100196354
    Abstract: The present invention relates to methods and compositions for modulating platelet activity by inhibiting or activating glutamate receptors. The invention further relates to preventing or treating thrombotic diseases.
    Type: Application
    Filed: January 16, 2008
    Publication date: August 5, 2010
    Applicant: THE JOHNS HOPKINS UNIVERSITY
    Inventors: Craig Norman Morrell, Charles J. Lowenstein
  • Treatments for male sexual dysfunction
    Patent number: 5439938
    Abstract: Methods and devices are taught for regulating penile erection and urethral function. Inhibitors of nitric oxide synthase and precursors of nitric oxide are applied to relax or contract the muscles of the corpus cavernosum and the urethra.
    Type: Grant
    Filed: April 7, 1993
    Date of Patent: August 8, 1995
    Assignee: The Johns Hopkins University
    Inventors: Solomon H. Snyder, Arthur L. Burnett, Charles J. Lowenstein, David S. Bredt, Thomas S. K. Chang